MAPT and early-onset autosomal dominant Alzheimer disease: We previously studied the clinical and pathological characteristics of a cohort of patients with Alzheimer’s disease and found a marked heterogeneity of tau seeding in this same biosensor line which was associated both with specific molecular characteristics of tau oligomers as well as differences in clinical disease progression.17